Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : STOCKS WITH ATTITUDE TEAM - FA/TA AND EVERYTHING ELSE -- Ignore unavailable to you. Want to Upgrade?

To: Amigo Mike who wrote (1658)	1/18/1998 8:28:00 PM
From: David Graham	Read Replies (2) \| Respond to of 2377

Michael, I think that with the fact that they have an accute respiratory distress drug that they will be fast tracked as it is a life threatening problem. They have about 14 dollars a share in cash as of the end of oct., and there is only 422,000 shares in the float and under a mill. total. they have addressed a market where there is no other drug currently available and the market is huge with approx. 150,000 cases per annum. More stuff also. Grammy